Advertisement · 728 × 90
#
Hashtag
#Vivus
Advertisement · 728 × 90
John Vandermosten
John Vandermosten
@vanjohn10.bsky.social
7 months ago
Video

@VIVUSLLC’s CEO John Amos examines the challenges with high dose GLP-1 agonists where patients may not get the expected benefits shown in studies
#WeightLoss #FatLoss #FitnessJourney #Nutrition #WeightManagement #DrugDevelopment #LifeSciences #Vivus #Pharmaceuticals #Biotech #Qsymia

0 0 0 0
John Vandermosten
John Vandermosten
@vanjohn10.bsky.social
7 months ago
Video

Vivus’ CEO John Amos reviews AI success rates for driving business impact.
Referenced article: fortune.com/2025/08/18/m...
#WeightLoss #PharmaManufacturing #DrugDevelopment #PharmaIndustry #LifeSciences #HealthcareSupplyChain #Vivus #Pharmaceuticals #Biotech #DrugDevelopment #Biopharma

1 0 0 0
John Vandermosten
John Vandermosten
@vanjohn10.bsky.social
7 months ago
Video

VIVUS LLC’ CEO John Amos reviews AI success rates for driving business impact.
Referenced article: fortune.com/2025/08/18/m...
#WeightLoss #HealthyLiving #FatLoss #FitnessJourney #LoseWeight #Nutrition #Vivus #Pharmaceuticals #Biotech

0 0 0 0
John Vandermosten
John Vandermosten
@vanjohn10.bsky.social
7 months ago
Video

#Vivus’ CEO John Amos explores the impacts of tariffs on the pharmaceutical supply chain.
#WeightLoss #PharmaSupplyChain #DrugDistribution #HealthcareLogistics #DrugDevelopment #PharmaIndustry #LifeSciences #HealthcareSupplyChain #Pharmaceuticals #Biotech #ObesityTreatment #Qsymia #Biopharma

0 0 0 0
John Vandermosten
John Vandermosten
@vanjohn10.bsky.social
7 months ago
Video

#Vivus’ John Amos on AI, the #FDA and what it’s like to work with the agency.
#Biopharma #Pharmaceuticals #Biotechnology #DrugDevelopment #Therapeutics #ObesityTreatment #CardiometabolicHealth #PharmaNews #BiotechInvesting #Biotech

1 0 0 0